Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD

References

• Miravitlles M, Dirksen A, Ferrarotti I, et al. European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency. Eur Respir J. 2017;50 1700610. doi: 10.1183/13993003.00610-2017.29191952
   PubMed Web of Science ®Google Scholar
• Hubbard RC, Fells G, Gadek J, et al. Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages. J Clin Invest. 1991;88:891–897.1653278
   PubMed Web of Science ®Google Scholar
• Barnes PJ Cellular and molecular mechanisms of chronic obstructive pulmonary disease. Clin Chest Med. 2014;35:71–86. doi:10.1016/j.ccm.2013.10.00424507838
   PubMed Web of Science ®Google Scholar
• Caramori G, Di Stefano A, Casolari P, et al. Chemokines and chemokine receptors blockers as new drugs for the treatment of chronic obstructive pulmonary disease. Curr Med Chem. 2013;20:4317–4349.24059236
   PubMed Web of Science ®Google Scholar
• Caramori G, Kirkham P, Barczyk A, et al. Molecular pathogenesis of cigarette smoking-induced stable COPD. Ann N Y Acad Sci. 2015;1340:55–64. doi: 10.1111/nyas.12619.25639503
   PubMed Web of Science ®Google Scholar
• Di Stefano A, Capelli A, Lusuardi M, et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med. 1998;158:1277–1285. doi:10.1164/ajrccm.158.4.98020789769292
   PubMed Web of Science ®Google Scholar
• Parr DG, White AJ, Bayley DL, et al. Inflammation in sputum relates to progression of disease in subjects with COPD: a prospective descriptive study. Respir Res. 2006;7:136. doi:10.1186/1465-9921-7-13617112387
   PubMed Web of Science ®Google Scholar
• Gompertz S, Bayley DL, Hill SL, et al. Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD. Thorax. 2001;56:36–41. doi:10.1136/thorax.56.1.3611120902
   PubMed Web of Science ®Google Scholar
• Saetta M, Di Stefano A, Maestrelli P, et al. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med. 1994;150:1646–1652. doi:10.1164/ajrccm.150.6.79526287952628
   PubMed Web of Science ®Google Scholar
• Hill AT, Bayley DL, Campbell EJ, et al. Airways inflammation in chronic bronchitis: the effects of smoking and alpha1-antitrypsin deficiency. Eur Respir J. 2000;15:886–890.10853853
   PubMed Web of Science ®Google Scholar
• Di Stefano A, Caramori G, Gnemmi I, et al. Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD. Thorax. 2009;64:968–975. doi:10.1136/thx.2009.11364719703829
   PubMed Web of Science ®Google Scholar
• Di Stefano A, Caramori G, Barczyk A, et al. Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD. Thorax. 2014;69(6):516–524. doi: 10.1136/thoraxjnl-2012-203062.24430176
   PubMed Web of Science ®Google Scholar
• Parr DG, Guest PG, Reynolds JH, et al. Prevalence and impact of bronchiectasis in alpha1-antitrypsin deficiency. Am J Respir Crit Care Med. 2007;176:1215–1221. doi:10.1164/rccm.200703-489OC17872489
   PubMed Web of Science ®Google Scholar
• Stone H, McNab G, Wood AM, et al. Variability of sputum inflammatory mediators in COPD and α1-antitrypsin deficiency. Eur Respir J. 2012;40:561–569. doi:10.1183/09031936.0016281122700846
   PubMed Web of Science ®Google Scholar
• Di Stefano A, Ricciardolo FLM, Caramori G, et al. Bronchial inflammation and bacterial load in stable COPD is associated with TLR4 overexpression. Eur Respir J. 2017;491602006. doi: 10.1183/13993003.02006-2016.28536249
   PubMed Web of Science ®Google Scholar
• Belkaid Y, Hand TW Role of the microbiota in immunity and inflammation. Cell. 2014;157:121–141. doi: 10.1016/j.cell.2014.03.01124679531
   PubMed Web of Science ®Google Scholar
• D’Anna SE, Balbi B, Cappello F, et al. Bacterial-viral load and the immune response in stable and exacerbated COPD: significance and therapeutic prospects. Int J Chron Obstruct Pulmon Dis. 2016;11:445–453. doi:10.2147/COPD.S9339827042037
   PubMed Web of Science ®Google Scholar
• Wewers MD, Casolaro MA, Sellers SE, et al. Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema. N Engl J Med. 1987;316:1055–1062. doi:10.1056/NEJM1987042331617043494198
   PubMed Web of Science ®Google Scholar
• Balbi B, Ferrarotti I, Miravitlles M Efficacy of augmentation therapy for emphysema associated with α1-antitrypsin deficiency: enough is enough. Eur Respir J. 2016;47:35–38. doi: 10.1183/13993003.01145-201526721962
   PubMed Web of Science ®Google Scholar
• Luisetti M, Ferrarotti I, Corda L, et al. Italian registry of patients with alpha-1 antitrypsin deficiency: general data and quality of life evaluation. COPD. 2015;12 Suppl 1:52–57. doi: 10.3109/15412555.2015.102339325938293
   PubMedGoogle Scholar
• Chapman KR, Burdon JG, Piitulainen E, et al. RAPID Trial Study Group. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial. Lancet. 2015;386(9991):360–368. doi: 10.1016/S0140-6736(15)60860-1.26026936
   PubMed Web of Science ®Google Scholar
• Lieberman J Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data. Chest. 2000;118:1480–1485. doi:10.1378/chest.118.5.148011083705
   PubMed Web of Science ®Google Scholar
• Stockley RA, Bayley DL, Unsal I, et al. The effect of augmentation therapy on bronchial inflammation in alpha1-antitrypsin deficiency. Am J Respir Crit Care Med. 2002;165:1494–1498. doi:10.1164/rccm.210901312045122
   PubMed Web of Science ®Google Scholar
• Erdman DD, Weinberg GA, Edwards KM, et al. GeneScan reverse transcription-PCR assay for detection of six common respiratory viruses in young children hospitalized with acute respiratory illness. J Clin Microbiol. 2003;41:4298–4303. doi:10.1128/jcm.41.9.4298-4303.200312958260
   PubMed Web of Science ®Google Scholar
• Ballows A, Hausler WJ, Herrmann KL, et al. Manual of Clinical Bacteriology. 5th ed. Washington DC: American Society for Microbiology; 1991.
   Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD) [homepage on the Internet]. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease; 2017 Available from: www.goldcopd.org. Accessed 1025, 2018.
   Google Scholar
• Stockley RA, Turner AM α-1-antitrypsin deficiency: clinical variability, assessment, and treatment. Trends Mol Med. 2014;20:105–115. doi:10.1016/j.molmed.2013.11.00624380646
   PubMed Web of Science ®Google Scholar
• Gottlieb DJ, Luisetti M, Stone PJ, et al. Short-term supplementation therapy does not affect elastin degradation in severe alpha(1)-antitrypsin deficiency. The American-Italian AATD Study Group. Am J Respir Crit Care Med 2000;162:2069–2072. doi:10.1164/ajrccm.162.6.200203211112116
   PubMed Web of Science ®Google Scholar
• Nakamura H, Yoshimura K, McElvaney NG, et al. Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. J Clin Invest. 1992;89:1478–1484. doi:10.1172/JCI1157381569186
   PubMed Web of Science ®Google Scholar
• Sapey E, Stockley JA, Greenwood H, et al. Behavioral and structural differences in migrating peripheral neutrophils from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;183:1176–1186. doi:10.1164/rccm.201008-1285OC21257786
   PubMed Web of Science ®Google Scholar
• Woolhouse IS, Bayley DL, Lalor P, et al. Endothelial interactions of neutrophils under flow in chronic obstructive pulmonary disease. Eur Respir J. 2005;25:612–617. doi:10.1183/09031936.05.0008630415802333
   PubMed Web of Science ®Google Scholar
• Rinchai D, Khaenam P, Kewcharoenwong C, et al. Production of interleukin-27 by human neutrophils regulates their function during bacterial infection. Eur J Immunol. 2012;42:3280–3290. doi: 10.1002/eji.201242526.22965735
   PubMed Web of Science ®Google Scholar
• Zhao X, SM T, CH L, et al. Neutrophil polarization by IL-27 as a therapeutic target for intracerebral hemorrhage. Nat Commun. 2017;8:602. doi: 10.1038/s41467-017-00770-728928459
   PubMed Web of Science ®Google Scholar
• Alagbe AE, Justo Junior AS, Ruas LP, et al. Interleukin-27 and interleukin-37 are elevated in sickle cell anemia patients and inhibit in vitro secretion of interleukin-8 in neutrophils and monocytes. Cytokine. 2018;107:85–92. doi:10.1016/j.cyto.2017.12.00129221667
   PubMed Web of Science ®Google Scholar
• Watzlawick R, Kenngott EE, Liu FD, et al. Anti-inflammatory effects of IL-27 in zymosan-induced peritonitis: inhibition of neutrophil recruitment partially explained by impaired mobilization from bone marrow and reduced chemokine levels. PLoS One. 2015;10(9):e0137651. doi: 10.1371/journal.pone.0137651.26360023
   PubMed Web of Science ®Google Scholar
• Caramori G, Di Stefano A, Casolari P, et al. Chemokines and chemokine receptors blockers as new drugs for the treatment of chronic obstructive pulmonary disease. Curr Med Chem. 2013;20:4317–4349.24059236
   PubMed Web of Science ®Google Scholar
• Lim MY, Yoon HS, Rho M, et al. Analysis of the association between host genetics, smoking, and sputum microbiota in healthy humans. Sci Rep. 2016;6:23745. doi: 10.1038/srep23745.27030383
   PubMed Web of Science ®Google Scholar
• Einarsson GG, Comer DM, McIlreavey L, et al. Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers. Thorax. 2016;71:795–803. doi:10.1136/thoraxjnl-2015-20723527146202
   PubMed Web of Science ®Google Scholar
• Cao J, Wang D, Xu F, et al. Activation of IL-27 signalling promotes development of postinfluenza pneumococcal pneumonia. EMBO Mol Med. 2014;6:120–140. doi:10.1002/emmm.20130289024408967
   PubMed Web of Science ®Google Scholar
• Gompertz S, Hill AT, Bayley DL, et al. Effect of expectoration on inflammation in induced sputum in alpha-1-antitrypsin deficiency.Respir Med. 2006;100:1094–1099. doi:10.1016/j.rmed.2005.09.02416257194
   PubMed Web of Science ®Google Scholar
• Griese M, Latzin P, Kappler M, et al. alpha1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients.Eur Respir J. 2007;29:240–250. doi:10.1183/09031936.00047306
   PubMed Web of Science ®Google Scholar